- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
OIG Expects Tighter Control on Compounded Drugs in CMS-Approved Hospitals
OIG recommends training for inspectors and amending contracts with stand-alone pharmacies to ensure improved quality and safety.
More than 2 years after drugs contaminated with a virulent fungus killed 64 patients and caused related illnesses in another 687, Medicare-approved hospital accreditors still don't properly oversee contracts hospitals have with compounding pharmacies to assure these drugs are safe, according to an Office of Inspector General report.
It recommends CMS consider requiring 55 practices to use accreditors to oversee compounded sterile preparations.
Link to the complete article on Medpage Today: http://bit.ly/1uY91MX
Price Transparency With Gaps: Assessing the Completeness of Payer Transparency in Coverage Data
December 9th 2025In analyzing 2025 Transparency in Coverage (TIC) files from national insurers, the authors found vast payer-level differences; overall, physician/outpatient data were more complete, and hospital inpatient data were less complete.
Read More
